Patents by Inventor Péter Tonka-Nagy

Péter Tonka-Nagy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8927021
    Abstract: The present invention relates to a process for manufacturing microcrystalline ezetimibe containing granulate, wherein a) ezetimibe is dissolved; b) the dissolved ezetimibe is precipitated with water, which if necessary contains pharmaceutical excipients, preferably lauryl-sulfate derivatives, and c) granulates are formed from the obtained suspension by spraying the suspension onto pharmaceutical excipients. A further aspect of the present invention is the granulate obtained by the present process and the pharmaceutical composition containing such granulate.
    Type: Grant
    Filed: February 24, 2010
    Date of Patent: January 6, 2015
    Assignee: Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszventarsasag
    Inventors: Zoltan Toelgyesi, Zsolt Zsigmond, Gyoergy Ujfalussy, Magdolna Leventiszne Huszar, Peter Tonka-Nagy, Monika Agyagos
  • Patent number: 8603537
    Abstract: Prasugrel containing quickly released stable oral pharmaceutical compositions containing micronized prasugrel base, and starch or a starch derivative, and processes for the preparation thereof, and the use thereof for treating atherothrombotic events of patients suffering from acute coronary syndrome in which patients were subjected to percutaneous coronary intervention.
    Type: Grant
    Filed: April 2, 2012
    Date of Patent: December 10, 2013
    Assignee: Egis Pharmaceuticals PLC
    Inventors: András Fehér, Zsolt Zsigmong, Péter Tonka-Nagy, György Tibor Ujfalussy
  • Publication number: 20130259904
    Abstract: Prasugrel containing quickly released stable oral pharmaceutical compositions containing micronized prasugrel base, and starch or a starch derivative, and processes for the preparation thereof, and the use thereof for treating atherothrombotic events of patients suffering from acute coronary syndrome in which patients were subjected to percutaneous coronary intervention.
    Type: Application
    Filed: April 2, 2012
    Publication date: October 3, 2013
    Applicant: EGIS PHARMACEUTICALS PLC
    Inventors: András FEHÉR, Zsolt Zsigmond, Péter Tonka-Nagy, György Tibor Ujfalussy
  • Publication number: 20120164227
    Abstract: The present invention relates to a process for manufacturing microcrystalline ezetimibe containing granulate, wherein a) ezetimibe is dissolved; b) the dissolved ezetimibe is precipitated with water, which if necessary contains pharmaceutical excipients, preferably lauryl-sulfate derivatives, and c) granulates are formed from the obtained suspension by spraying the suspension onto pharmaceutical excipients. A further aspect of the present invention is the granulate obtained by the present process and the pharmaceutical composition containing such granulate.
    Type: Application
    Filed: February 24, 2010
    Publication date: June 28, 2012
    Inventors: Zoltan Toelgyesi, Zsolt Zsigmond, Gyoergy Ujfalussy, Magdolna Leventiszne Huszar, Peter Tonka-Nagy, Monika Agyagos